These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 19584730)
1. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Perl A Curr Opin Rheumatol; 2009 Sep; 21(5):443-7. PubMed ID: 19584730 [TBL] [Abstract][Full Text] [Related]
2. Pathogenic mechanisms in systemic lupus erythematosus. Perl A Autoimmunity; 2010 Feb; 43(1):1-6. PubMed ID: 20014960 [TBL] [Abstract][Full Text] [Related]
3. Update on infections and vaccinations in systemic lupus erythematosus and Sjögren's syndrome. Pasoto SG; Ribeiro AC; Bonfa E Curr Opin Rheumatol; 2014 Sep; 26(5):528-37. PubMed ID: 25022358 [TBL] [Abstract][Full Text] [Related]
4. B cell depletion in lupus and Sjögren's syndrome: an update. Coca A; Sanz I Curr Opin Rheumatol; 2009 Sep; 21(5):483-8. PubMed ID: 19644378 [TBL] [Abstract][Full Text] [Related]
7. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]. Ampélas JF; Wattiaux MJ; Van Amerongen AP Encephale; 2001; 27(6):588-99. PubMed ID: 11865567 [TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C. Onishi S; Nagashima T; Kimura H; Matsuyama Y; Yoshio T; Minota S Lupus; 2010 May; 19(6):753-5. PubMed ID: 20064909 [TBL] [Abstract][Full Text] [Related]
10. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives. Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133 [TBL] [Abstract][Full Text] [Related]
11. Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies. Vossenkämper A; Lutalo PM; Spencer J Clin Exp Immunol; 2012 Jan; 167(1):7-14. PubMed ID: 22132879 [TBL] [Abstract][Full Text] [Related]
12. Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome. Coca A; Sanz I Curr Opin Rheumatol; 2012 Sep; 24(5):451-6. PubMed ID: 22871954 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren's syndrome in familial systemic lupus. Scofield RH; Bruner GR; Harley JB; Namjou B Ann Rheum Dis; 2007 Mar; 66(3):410-3. PubMed ID: 16984944 [TBL] [Abstract][Full Text] [Related]